Stay updated on INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.

Latest updates to the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page
- ChecktodayChange DetectedThe page's revision tag was updated to v3.6.3, replacing the previous v3.6.0. This reflects a software update applied to the page's system.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew user guidance sections have been added and the Intervention/Treatment label adjusted, with the revision tag updated to v3.6.0. The notice that recruitment is closed indicates enrollment is no longer open.SummaryDifference0.3%

- Check22 days agoChange DetectedThe page revision has been updated to v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, representing a small update to the page's revision metadata.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the underlying study information.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.5.2 has been introduced, replacing the previous v3.5.0.SummaryDifference0.0%

Stay in the know with updates to INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.